39 research outputs found

    Mapping genome-wide neuropsychiatric mutation effects on functional brain connectivity : c opy number variants delineate dimensions contributing to autism and schizophrenia

    Full text link
    Les recherches menĂ©es pour comprendre les troubles du spectre autistique (TSA) et la schizophrĂ©nie (SZ) ont communĂ©ment utilisĂ© une approche dite descendante, partant du diagnostic clinique pour investiguer des phĂ©notypes intermĂ©diaires cĂ©rĂ©braux ainsi que des variations gĂ©nĂ©tiques associĂ©es. Des Ă©tudes transdiagnostiques rĂ©centes ont remis en question ces frontiĂšres nosologiques, et suggĂšrent des mĂ©canismes Ă©tiologiques imbriquĂ©s. L’approche montante propose de composer des groupes de porteurs d’un mĂȘme variant gĂ©nĂ©tique afin d’investiguer leur contribution aux conditions neuropsychiatriques (NPs) associĂ©es. Les variations du nombre de copies (CNV, perte ou gain d’un fragment d’ADN) figurent parmi les facteurs biologiques les plus associĂ©s aux NPs, et sont dĂšs lors des candidats particuliĂšrement appropriĂ©s. Les CNVs induisant un risque pour des conditions similaires, nous posons l’hypothĂšse que des classes entiĂšres de CNVs convergent sur des dimensions d’altĂ©rations cĂ©rĂ©brales qui contribuent aux NPs. L’imagerie fonctionnelle au repos (rs-fMRI) s’est rĂ©vĂ©lĂ©e un outil prometteur en psychiatrie, mais presqu’aucune Ă©tude n’a Ă©tĂ© menĂ©e pour comprendre l’impact des CNVs sur la connectivitĂ© fonctionnelle cĂ©rĂ©brale (FC). Nos objectifs Ă©taient de: 1) CaractĂ©riser l’effet des CNVs sur la FC; 2) Rechercher la prĂ©sence des motifs confĂ©rĂ©s par ces signatures biologiques dans des conditions idiopathiques; 3) Tester si la suppression de gĂšnes intolĂ©rants Ă  l’haploinsuffisance rĂ©organise la FC de maniĂšre indĂ©pendante Ă  leur localisation dans le gĂ©nome. Nous avons agrĂ©gĂ© des donnĂ©es de rs-fMRI chez: 502 porteurs de 8 CNVs associĂ©es aux NPs (CNVs-NP), de 4 CNVs sans association Ă©tablie, ainsi que de porteurs de CNVs-NPs Ă©parses; 756 sujets ayant un diagnostic de TSA, de SZ, ou de trouble dĂ©ficitaire de l’attention/hyperactivitĂ© (TDAH), et 5377 contrĂŽles. Les analyses du connectome entier ont montrĂ© un effet de dosage gĂ©nique positif pour les CNVs 22q11.2 et 1q21.1, et nĂ©gatif pour le 16p11.2. La taille de l’effet des CNVs sur la FC Ă©tait corrĂ©lĂ©e au niveau de risque psychiatrique confĂ©rĂ© par le CNV. En accord avec leurs effets sur la cognition, l’effet des dĂ©lĂ©tions sur la FC Ă©tait plus Ă©levĂ© que celui des duplications. Nous avons identifiĂ© des similaritĂ©s entre les motifs cĂ©rĂ©braux confĂ©rĂ©s par les CNVs-NP, et l’architecture fonctionnelle des individus avec NPs. Le niveau de similaritĂ© Ă©tait associĂ© Ă  la sĂ©vĂ©ritĂ© du CNV, et Ă©tait plus fort avec la SZ et les TSA qu’avec les TDAH. La comparaison des motifs confĂ©rĂ©s par les dĂ©lĂ©tions les plus sĂ©vĂšres (16p11.2, 22q11.2) Ă  l’échelle fonctionnelle, et d’expression gĂ©nique, nous a confirmĂ© l’existence prĂ©sumĂ©e de relation entre les mutations elles-mĂȘmes. À l’aide d’une mesure d’intolĂ©rance aux mutations (pLI), nous avons pu inclure tous les porteurs de CNVs disponibles, et ainsi identifier un profil d’haploinsuffisance impliquant le thalamus, le cortex antĂ©rieur cingulaire, et le rĂ©seau somato-moteur, associĂ© Ă  une diminution de mesure d’intelligence gĂ©nĂ©rale. Enfin, une analyse d’exploration factorielle nous a permis de confirmer la contribution de ces rĂ©gions cĂ©rĂ©brales Ă  3 composantes latentes partagĂ©es entre les CNVs et les NPs. Nos rĂ©sultats ouvrent de nouvelles perspectives dans la comprĂ©hension des mĂ©canismes polygĂ©niques Ă  l’oeuvre dans les maladies mentales, ainsi que des effets plĂ©iotropiques des CNVs.Research on Autism Spectrum Disorder (ASD) and schizophrenia (SZ) has mainly adopted a ‘top-down’ approach, starting from psychiatric diagnosis, and moving to intermediate brain phenotypes and underlying genetic factors. Recent cross-disorder studies have raised questions about diagnostic boundaries and pleiotropic mechanisms. By contrast, the recruitment of groups based on the presence of a genetic risk factor allows for the investigation of molecular pathways related to a particular risk for neuropsychiatric conditions (NPs). Copy number variants (CNVs, loss or gain of a DNA segment), which confer high risk for NPs are natural candidates to conduct such bottom-up approaches. Because CNVs have a similar range of adverse effects on NPs, we hypothesized that entire classes of CNVs may converge upon shared connectivity dimensions contributing to mental illness. Resting-state functional MRI (rs-fMRI) studies have provided critical insight into the architecture of brain networks involved in NPs, but so far only a few studies have investigated networks modulated by CNVs. We aimed at 1) Delineating the effects of neuropsychiatric variants on functional connectivity (FC), 2) Investigating whether the alterations associated with CNVs are also found among idiopathic psychiatric populations, 3) Testing whether deletions reorganize FC along general dimensions, irrespective of their localization in the genome. We gathered rsfMRI data on 502 carriers of eight NP-CNVs (high-risk), four CNVs without prior association to NPs as well as carriers of eight scarcer NP-CNVs. We also analyzed 756 subjects with idiopathic ASD, SZ, and attention deficit hyperactivity disorder (ADHD), and 5,377 controls. Connectome-wide analyses showed a positive gene dosage effect for the 22q11.2 and 1q21.1 CNVs, and a negative association for the 16p11.2 CNV. The effect size of CNVs on relative FC (mean-connectivity adjusted) was correlated with the known level of NP-risk conferred by CNVs. Consistent with results on cognition, we also reported that deletions had a larger effect size on FC than duplications. We identified similarities between high-risk CNV profiles and the connectivity architecture of individuals with NPs. The level of similarity was associated with mutation severity and was strongest in SZ, followed by ASD, and ADHD. The similarity was driven by the thalamus, and the posterior cingulate cortex, previously identified as hubs in transdiagnostic psychiatric studies. These results raised questions about shared mechanisms across CNVs. By comparing deletions at the 16p11.2 and 22q11.2 loci, we identified similarities at the connectivity, and at the gene expression level. We extended this work by pooling all deletions available for analysis. We asked if connectivity alterations were associated with the severity of deletions scored using pLI, a measure of intolerance to haploinsufficiency. The haploinsufficiency profile involved the thalamus, anterior cingulate cortex, and somatomotor network and was correlated with lower general intelligence and higher autism severity scores in 3 unselected and disease cohorts. An exploratory factor analysis confirmed the contribution of these regions to three latent components shared across CNVs and NPs. Our results open new avenues for understanding polygenicity in psychiatric conditions, and the pleiotropic effect of CNVs on cognition and on risk for neuropsychiatric disorders

    Scalable Machine Learning Methods for Massive Biomedical Data Analysis.

    Full text link
    Modern data acquisition techniques have enabled biomedical researchers to collect and analyze datasets of substantial size and complexity. The massive size of these datasets allows us to comprehensively study the biological system of interest at an unprecedented level of detail, which may lead to the discovery of clinically relevant biomarkers. Nonetheless, the dimensionality of these datasets presents critical computational and statistical challenges, as traditional statistical methods break down when the number of predictors dominates the number of observations, a setting frequently encountered in biomedical data analysis. This difficulty is compounded by the fact that biological data tend to be noisy and often possess complex correlation patterns among the predictors. The central goal of this dissertation is to develop a computationally tractable machine learning framework that allows us to extract scientifically meaningful information from these massive and highly complex biomedical datasets. We motivate the scope of our study by considering two important problems with clinical relevance: (1) uncertainty analysis for biomedical image registration, and (2) psychiatric disease prediction based on functional connectomes, which are high dimensional correlation maps generated from resting state functional MRI.PhDElectrical Engineering: SystemsUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttp://deepblue.lib.umich.edu/bitstream/2027.42/111354/1/takanori_1.pd

    The topology of structural brain connectivity in diseases and spatio-temporal connectomics

    Get PDF
    The brain is a complex system, composed of multiple neural units interconnected at different spatial and temporal scales. Diffusion MRI allows probing in vivo the anatomical connectivity between different cortical areas through white matter tracts. In parallel, functional MRI records neural-related signals of brain activity. Particularly, during rest (in absence of specific external task) reproducible dynamical patterns of functional synchronization have been shown across different brain areas. This rich information can be conveniently represented in the form of a graph, a mathematical object where nodes correspond to cortical regions and are connected by edges representing anatomical connections. On the top of this structural network, or brain connectome, individual nodes are associated to functional signals representing neural activity over observation periods. Network science has fundamentally contributed to the characterization of the human connectome. The brain is a small-world network, able to combine segregation and integration aspects. These properties allow functional specialization on the one side, and efficient communication between distant brain areas on the other side, supporting complex cognitive and executive functions. Graph theoretical methods quantify brain topological properties, and allow their comparison between different populations and conditions. In fact, brain connectivity patterns and interdependences between anatomical substrate and functional synchronization have been proved to be impaired in a variety of brain disorders, and to change across human development and aging. Despite these important advancements in the understanding of the brain structure and functioning, many questions are currently unanswered. It is not clear for instance how structural connectivity features are related to individual cognitive capabilities and deficits, and if they have the concrete potential to distinguish pathological subgroups for early diagnosis of brain diseases. Most importantly, it is not yet understood how the connectome topology relates to specific brain functions, and how the transmission of information happens on the top of the structural connectivity infrastructure in order to generate observed functional dynamics. This thesis was motivated by these interdisciplinary inputs, and is the result of a strong interaction between biological and clinical questions on the one hand, and methodological development needs on the other hand. First, we have contributed to the characterization of the human connectome in health and pathologies by adapting and developing network measures for the description of the brain architecture at different scales. Particularly, we have focused on the topological characterization of subnetworks role within the overall brain network. Importantly, we have shown that the topological alteration of distinct brain subsystems may be a biomarker for different brain disorders. Second, we have proposed an original network model for the joint representation of brain structural and functional connectivity properties. This flexible spatio-temporal framework allows the investigation of functional dynamics at multiple temporal scales. Importantly, the investigation of spatio-temporal graphs in healthy subjects have allowed to disclose temporal relationships between local brain activations in resting state recordings, and has highlighted functional communication principles across the brain structural network

    Impact Of Adverse Childhood Experiences On Behavioral And Neural Markers Of Executive Function In Menopausal Women

    Get PDF
    Many healthy women with no history of cognitive dysfunction experience subjective executive difficulties during menopause. Indicators of risk for executive function difficulties at menopause are lacking, as is a mechanistic understanding of how loss of estradiol unmasks this vulnerability. We hypothesized that adverse childhood experiences (ACE) increase the risk of executive dysfunction during menopause via alterations in monoaminergic neurotransmission. To test this hypothesis, we evaluated the effect of ACE on subjective and objective measures of executive function as well as executive activation, functional connectivity, and neurochemistry. We used tryptophan depletion (TD) and lisdexamfetamine (LDX) to probe serotonergic and catecholaminergic function, respectively. High ACE women endorsed greater symptoms of executive dysfunction and performed worse on tasks probing sustained attention and working memory. These negative ACE effects were partially mediated by anxiety and depressive symptoms. ACE moderated the impact of TD on DLPFC activation in hypogonadal women such that TD increased activation in high ACE participants but decreased activation in low ACE participants. Importantly, treatment with estradiol attenuated the effects of both ACE and TD. ACE similarly moderated the impact of TD on within-network connectivity. While ACE was associated with lower within-network connectivity regardless of depletion condition, TD increased connectivity in the high ACE group but had no effect on connectivity in the low ACE group. ACE also moderated response to LDX. In the high ACE group, LDX (vs placebo) increased activation in the insula and reduced symptoms related to difficulty with organization and activation for work. In contrast, response to LDX was not significantly different from placebo in the low ACE group. These results have several clinical and mechanistic implications. First, they highlight that addressing concurrent mood changes is a critical step in treating menopause-induced executive difficulties. Second, this work suggests that early life adversity has latent impacts on serotonergic circuits underlying executive function that are unmasked by loss of estradiol during menopause. Third, they indicate that early adversity may have lasting effects on catecholaminergic neurotransmission and may moderate response to stimulant medications. Together, they emphasize the importance of considering ACE when treating executive difficulties with pharmacologic agents during menopause

    Using neurobiological measures to predict and assess trauma-focused psychotherapy outcome in youth with posttraumatic stress disorder

    Get PDF
    In this thesis we examined different predictive neurobiological measures of traumafocused psychotherapy response and investigated the biological mechanisms underlying trauma-focused psychotherapy response in youth with PTSD. Our results suggest that activity of the major neuroendocrine stress response systems and brain functional connectivity before treatment are indeed associated with trauma-focused treatment response. Moreover, trauma-focused psychotherapy response seems to be related to longitudinal changes in autonomic nervous system activity during stress and brain structure. Together, these findings improve our understanding of the relationship between neurobiological measures and traumafocused psychotherapy response in youth with PTSD. However, these insights have currently limited to no clinical value because the current state of evidence does not support implementation of neurobiological biomarkers for treatment selection and necessary trials of (augmentation) treatments targeting neurobiological mechanisms related to treatment response have not been performed yet. The way forward now, is to perform individual prediction studies in less heterogeneous patient samples and to perform developmentally informed long-term studies examining (neuro) developmental trajectories related to PTSD and treatment response. These studies are necessary to address whether neurobiological measures can eventually improve treatment outcome and reduce the burden of PTSD in affected youth

    Do informal caregivers of people with dementia mirror the cognitive deficits of their demented patients?:A pilot study

    Get PDF
    Recent research suggests that informal caregivers of people with dementia (ICs) experience more cognitive deficits than noncaregivers. The reason for this is not yet clear. Objective: to test the hypothesis that ICs ‘mirror' the cognitive deficits of the demented people they care for. Participants and methods: 105 adult ICs were asked to complete three neuropsychological tests: letter fluency, category fluency, and the logical memory test from the WMS-III. The ICs were grouped according to the diagnosis of their demented patients. One-sample ttests were conducted to investigate if the standardized mean scores (t-scores) of the ICs were different from normative data. A Bonferroni correction was used to correct for multiple comparisons. Results: 82 ICs cared for people with Alzheimer's dementia and 23 ICs cared for people with vascular dementia. Mean letter fluency score of the ICs of people with Alzheimer's dementia was significantly lower than the normative mean letter fluency score, p = .002. The other tests yielded no significant results. Conclusion: our data shows that ICs of Alzheimer patients have cognitive deficits on the letter fluency test. This test primarily measures executive functioning and it has been found to be sensitive to mild cognitive impairment in recent research. Our data tentatively suggests that ICs who care for Alzheimer patients also show signs of cognitive impairment but that it is too early to tell if this is cause for concern or not
    corecore